Nontraditional Uses of Continuous Glucose Monitoring

2022, 7. Diabetes technology: Standards of Medical Care in Diabetes—2022, Diabetes Care, 45, S97 Beck, 2017, Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial, JAMA, 317, 371, 10.1001/jama.2016.19975 Lind, 2017, Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial, JAMA, 317, 379, 10.1001/jama.2016.19976 Martens, 2021, Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial, JAMA, 325, 2262, 10.1001/jama.2021.7444 Deshmukh, 2020, Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit, Diabetes Care, 43, 2153, 10.2337/dc20-0738 Heinemann, 2018, Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial, Lancet, 391, 1367, 10.1016/S0140-6736(18)30297-6 Beck, 2022, Non-adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): results of a post-approval observational study, Diabet Med, 39, 10.1111/dme.14739 Nathanson, 2021, Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls, Diabetologia, 64, 1595, 10.1007/s00125-021-05437-z Polonsky, 2017, The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial, Diabetes Care, 40, 736, 10.2337/dc17-0133 Charleer, 2020, Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study, Diabetes Care, 43, 389, 10.2337/dc19-1610 Hirsch, 2021, Integrating continuous glucose monitoring into clinical practices and patients’ lives, Diabetes Technol Ther, 23, S72, 10.1089/dia.2021.0233 Steck, 2022, CGM metrics predict imminent progression to type 1 diabetes: Autoimmunity Screening for Kids (ASK) Study, Diabetes Care, 45, 365, 10.2337/dc21-0602 Hoss, 2014, Feasibility of using a factory-calibrated CGM system to diagnose type 2 diabetes, J Diabetes Sci Technol, 8, 89, 10.1177/1932296813511747 Shah, 2019, Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study, J Clin Endocrinol Metab, 104, 4356, 10.1210/jc.2018-02763 Nguyen, 2018, Use of continuous glucose monitoring in detecting reactive hypoglycemia in individuals without diabetes, J Diabetes Sci Technol, 12, 1244, 10.1177/1932296818777273 Jaklevic, 2021, Start-ups tout continuous glucose monitoring for people without diabetes, JAMA, 325, 2140, 10.1001/jama.2021.3789 Vitale, 2021, Blood glucose and subcutaneous continuous glucose monitoring in critically ill horses: a pilot study, PLoS One, 16, e0247561, 10.1371/journal.pone.0247561 Ehrhardt, 2020, Continuous glucose monitoring as a behavior modification tool, Clin Diabetes, 38, 126, 10.2337/cd19-0037 Yoo, 2008, Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes, Diabetes Res Clin Pract, 82, 73, 10.1016/j.diabres.2008.06.015 Bergenstal, 2021, Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic, Diabetes Technol Ther, 23, 128, 10.1089/dia.2020.0396 Martens, 2021, Primary care and diabetes technologies and treatments, Diabetes Technol Ther, 23, S143, 10.1089/dia.2021.2510 Shrivastav, 2018, Type 2 diabetes management in primary care: the role of retrospective, professional continuous glucose monitoring, Diabetes Spectr, 31, 279, 10.2337/ds17-0024 Johnson, 2019, Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice, Diabetes Technol Ther, 21, S217, 10.1089/dia.2019.0034 Battelino, 2019, Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range, Diabetes Care, 42, 1593, 10.2337/dci19-0028 Ehrhardt, 2019, Behavior modification in prediabetes and diabetes: potential use of real-time continuous glucose monitoring, J Diabetes Sci Technol, 13, 271, 10.1177/1932296818790994 Lupoli, 2022, Rate of post-bariatric hypoglycemia using continuous glucose monitoring: a meta-analysis of literature studies, Nutr Metab Cardiovasc Dis, 32, 32, 10.1016/j.numecd.2021.08.047 Vigersky, 2019, Going beyond HbA1c to understand the benefits of advanced diabetes therapies, J Diabetes, 11, 23 Beck, 2017, The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading, Diabetes Care, 40, 994, 10.2337/dc17-0636 Schumacher, 2022, A misdiagnosis of type 2 diabetes mellitus: using continuous glucose monitoring to improve patient-centered care, J Am Pharm Assoc, 62, 281, 10.1016/j.japh.2021.09.007 Bellido, 2021, Time-in-range for monitoring glucose control: is it time for a change?, Diabetes Res Clin Pract, 177, 10.1016/j.diabres.2021.108917 Beck, 2021, Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve, Diabetes Spectr, 34, 102, 10.2337/ds20-0090 Cox, 2020, Minimizing glucose excursions (GEM) with continuous glucose monitoring in type 2 diabetes: a randomized clinical trial, J Endocr Soc, 4, 1 Taylor, 2019, Efficacy of real-time continuous glucose monitoring to improve effects of a prescriptive lifestyle intervention in type 2 diabetes: a pilot study, Diabetes Ther, 10, 509, 10.1007/s13300-019-0572-z Kruger, 2021, Continuous glucose monitoring (CGM) is a tool, not a reward: unjustified insurance coverage criteria limit access to CGM, Diabetes Technol Ther, 23, S45, 10.1089/dia.2021.0193 Galindo, 2021, What’s wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring, Diabetes Technol Ther, 23, 652, 10.1089/dia.2021.0107 Edelman, 2021, Utilizing continuous glucose monitoring in primary care practice: what the numbers mean, Prim Care Diabetes, 15, 199, 10.1016/j.pcd.2020.10.013